AI assistant
Adastra Holdings — Board/Management Information 2021
Mar 30, 2021
44131_rns_2021-03-29_fc084edc-5a46-4dc6-9628-ee03a833b1e6.pdf
Board/Management Information
Open in viewerOpens in your device viewer
FORM 51-102F3 MATERIAL CHANGE REPORT
Item 1 Name and Address of Company
Adastra Labs Holdings Ltd. 5451 - 275 Street Langley, BC V4W 3X8
Item 2 Date of Material Change
March 26, 2021
Item 3 News Release
The news release was issued and disseminated on March 29, 2021 and filed on SEDAR at www.sedar.com, a copy of which is attached hereto as Schedule “A”.
Item 4 Summary of Material Change
The Company announced that Blaine Bailey has resigned as a director of the Company.
Item 5 Full Description of Material Change
5.1 Full Description of Material Change
Please see the news release attached as Schedule “A” for a full description of the material change.
- 5.2 Disclosure for Restructuring Transactions
Not applicable
Item 6 Reliance on Subsection 7.1(2) of National Instrument 51-102
Not applicable.
Item 7 Omitted Information
Not applicable.
Item 8 Executive Officer
J. Scott Munro
President, Chief Executive Officer & Director (778) 715-5011
Item 9 Date of Report
March 29, 2021
Schedule “A”
==> picture [73 x 55] intentionally omitted <==
ADASTRA LABS ANNOUNCES DIRECTOR RESIGNATION
==> picture [86 x 17] intentionally omitted <==
LANGLEY, BC / STOCKWATCH / March 29, 2021 - Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra Labs” or the “Company) announces the resignation of Blaine Bailey as a director of the Company. Adastra’s board is currently assessing candidates to replace Mr. Bailey that will also be subject to completion of Health Canada security clearances.
About Adastra Labs
Adastra Labs is an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) and Analytical Testing Laboratory (Chemia Analytics) facilities. Chemia Analytics is a wholly owned subsidiary of the Company. The Company also has an R&D license amendment pending Health Canada approval.
About Phyto Extractions™ Brands
Phyto Extractions™ products have been available in the regulated Canadian cannabis market since December 2019 when they launched 4 SKUs. Since that time, the brand has grown over four-fold to offer 18 SKUs including 0.3-gram disposable vaporizers (vapes) in four strains/flavours, 0.5-gram vaporizing cartridges in six strains/flavours with one kit, recently expanded to the 1.0-gram cartridge format in four strains/flavours, two strains of Live Resin and a unique High-Terpene Full Spectrum Extract (HTFSE) terp sauce SKU. Phyto Extractions™ has new product launches planned for 2021, including edibles, beverages, flower (bags, pre-rolls), hydrocarbon extracts (butter, diamond, shatter, terp sauce, wax), and topicals (roll-on, creams, oils, oral spray, path).
Phyto Extractions™ products are currently sold in the provinces of BC, AB, MB, SK and ON.
==> picture [433 x 114] intentionally omitted <==
Figure 1 – Phyto Extractions Line Up of Concentrate Products and power cell.